“The FLCCC's Flavio Cadegiani performed one of the highest-quality studies in COVID, finding unprecedented reductions in mortality with proxalutamide. He has been under attack ever since.”
Read more
“Researchers in Brazil found that regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization and mortality rates.”
Read more